Almac Group
Almac is a pharmaceutical service provider with over 30 years experience. The company provides a range of services including research and development, pharmaceutical testing and clinical trials as well as the commercialisation of pharmaceutical products. The company has experience in biomarker discovery and development through its partners and through internal R&D.
Almac provides comprehensive support from drug discovery through to scale-up and launch of new drugs. Pharmaceutical development includes pre-formulation of drugs, testing and taking them to market. The company has three chemical trial sites globally, with one in Northern Ireland situated at Craigavon.
The company also specialises in the design and manufacture of drug packaging including blistering, bottling and walleting/carding of pharmaceuticals.
Financial Data
-
30th Sep 16 Source: CRO
- €507.1 million turnover
-
€30.4 million
profit - 3,975 employees
-
30th Sep 15 Source: CRO
- €463.8 million turnover
-
€33 million
profit - 3,554 employees
- 8 more years available »
Ranking
By Turnover
(€507.1 million)- 143rd in Top Companies
- 22nd in Health
By Employees
(3,975)- 53rd in Top Companies
- 8th in Health
-
- 3,975
- €507.1 million
Employees
- Alan Armstrong CEO/Managing Director
Latest News
- 4:25am Doyle hotels report no adverse impact from Brexit
- 4:15am Just 33 affordable mortgages drawn down in Dublin city
- 4:00am France faces growing threat of skills shortages
- 2:25am Government had ‘open door’ policy towards NBP bidder, TD claims
- 1:00am Some retirees facing mandatory higher pension drawdowns